Suppr超能文献

不同地理区域患者美洲大蠊()过敏的组分解析诊断

Component-Resolved Diagnosis of American Cockroach () Allergy in Patients From Different Geographical Areas.

作者信息

Wangorsch Andrea, Jamin Annette, Eichhorn Stephanie, Pablos Isabel, Sharma Swati, Schweidler Bettina, Kastner Bianca, Wildner Sabrina, Saloga Joachim, Führer Frank, Reyna Orozco Reinaldo Rafael, Sherkat Roya, Sadeghi Somayeh, Teifoori Fardis, Park Jung-Won, Briza Peter, Vieths Stefan, Ferreira Fatima, Arora Naveen, Lidholm Jonas, Gadermaier Gabriele, Scheurer Stephan

机构信息

Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.

Department of Biosciences, Paris Lodron University of Salzburg, Salzburg, Austria.

出版信息

Front Allergy. 2021 Jun 29;2:691627. doi: 10.3389/falgy.2021.691627. eCollection 2021.

Abstract

Manifestation of respiratory allergy to American cockroach () is prominent in the subtropical and tropical areas. However, co-existing perennial indoor inhalant allergies frequently compromise clinical diagnosis of cockroach allergy, and the analysis of sensitization pattern is limited by the lack of allergens widely available for component-resolved diagnostics (CRD). To evaluate a collection of previously described recombinant allergens for CRD in cockroach allergy. A panel of nine recombinant a allergens (Per a 1-5, 7-10) was generated, purified, and subjected to physicochemical characterization by applying circular dichroism (CD) spectroscopy, dynamic light scattering (DLS), amino acid (AA) analysis, and mass spectrometry (MS). Patients ( = 117) from India, Korea, Venezuela, and Iran, reporting perennial respiratory indoor allergies with IgE sensitization to cockroach (), were included. The sensitization profile was monitored by the experimental ImmunoCAP testing. ImmunoCAP testing confirmed IgE sensitization to and/or extract in 98 of 117 patients ( = 0.95). Five out of 117 patients were sensitized to only one of the two cockroach species. Within the whole study group, the prevalence of sensitization to individual allergens varied from 4% (Per a 2) to 50% (Per a 9), with the highest IgE values to Per a 9. Patients from four countries displayed different sensitization profiles at which Per a 3 and Per a 9 were identified as major allergens in India and Korea. -derived lipocalin and myosin light chain were characterized as new minor allergens, designated as Per a 4 and Per a 8. extract showed higher diagnostic sensitivity than all individual components combined, suggesting the existence of allergens yet to be discovered. Utilization of a panel of purified allergens revealed highly heterogeneous sensitization patterns and allowed the classification of lipocalin and myosin light chain from as new minor allergens.

摘要

在美国蟑螂()引起的呼吸道过敏中,其表现形式在亚热带和热带地区较为突出。然而,常年并存的室内吸入性过敏常常会影响蟑螂过敏的临床诊断,并且由于缺乏广泛用于组分分辨诊断(CRD)的过敏原,致敏模式的分析受到限制。为了评估一组先前描述的重组过敏原在蟑螂过敏CRD中的作用。生成了一组九种重组a过敏原(变应原美洲大蠊1 - 5、7 - 10),进行了纯化,并通过应用圆二色性(CD)光谱、动态光散射(DLS)、氨基酸(AA)分析和质谱(MS)对其进行了物理化学表征。纳入了来自印度、韩国、委内瑞拉和伊朗的117名患者,这些患者报告有常年性呼吸道室内过敏且对蟑螂()有IgE致敏。通过实验性免疫捕获检测监测致敏情况。免疫捕获检测证实117名患者中有98名(= 0.95)对美洲大蠊提取物和/或德国小蠊提取物有IgE致敏。117名患者中有5名仅对两种蟑螂中的一种致敏。在整个研究组中,对单个过敏原的致敏率从4%(变应原美洲大蠊2)到50%(变应原美洲大蠊9)不等,对变应原美洲大蠊9的IgE值最高。来自四个国家的患者表现出不同的致敏模式,其中变应原美洲大蠊3和变应原美洲大蠊9在印度和韩国被确定为主要过敏原。源自德国小蠊的脂质运载蛋白和肌球蛋白轻链被鉴定为新的次要过敏原,分别命名为变应原德国小蠊4和变应原德国小蠊8。美洲大蠊提取物显示出比所有单个组分组合更高的诊断敏感性,这表明还有尚未发现的过敏原。使用一组纯化的蟑螂过敏原揭示了高度异质的致敏模式,并将源自德国小蠊的脂质运载蛋白和肌球蛋白轻链分类为新的次要过敏原。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验